Viewing Study NCT07140757


Ignite Creation Date: 2025-12-24 @ 6:32 PM
Ignite Modification Date: 2026-01-02 @ 12:03 PM
Study NCT ID: NCT07140757
Status: RECRUITING
Last Update Posted: 2025-08-26
First Post: 2025-08-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Overview

Official Title: Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers
Status: RECRUITING
Status Verified Date: 2025-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To track the outcomes of patients who have been treated with RFA and its long-term effectiveness, and to learn more about the quality of life of patients who have received RFA in this study.
Detailed Description: Primary Objectives

• To evaluate thyroid nodule volume changes over time in participants undergoing RFA as part of clinical care

Secondary Objectives

* To establish the health-related quality of life among participants undergoing with ultrasound guided RFA.
* To evaluate the sonographic features of thyroid nodules over time following ultrasound guided RFA.
* To assess adverse events rates following ultrasound guided RFA.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
NCI-2025-06179 OTHER NCI-CTRP Clinical Registry View